NCT01774981 - Study of LY3016859 in Participants With Diabetic Nephropathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Diabetic Nephropathy

Interventions

DRUG

Placebo

Administered IV

DRUG

LY3016859

Administered IV

Trial Locations (7)

1612

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sofia

18017

Northeast Clinical Research Center, Bethlehem

33756

Innovative Research of West Florida, Clearwater

37408

Southeast Renal Research Institute, Chattanooga

68131

Creighton University Medical Center, Omaha

75904

TAD Clinical Research, Lufkin

78215

Renal Associates, PA, San Antonio

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY